Home/Filings/4/0001127602-25-006578
4//SEC Filing

Guerrero Ramiro 4

Accession 0001127602-25-006578

CIK 0001878313other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 4:11 PM ET

Size

6.9 KB

Accession

0001127602-25-006578

Insider Transaction Report

Form 4
Period: 2025-02-24
Transactions
  • Purchase

    Common Stock

    2025-02-24$1.50/sh+73,333$110,000534,885 total
  • Purchase

    Warrants

    2025-02-24$1.87/sh+73,333$137,13373,333 total
    Exercise: $1.87From: 2025-08-24Exp: 2030-08-24Common Stock (73,333 underlying)
Footnotes (2)
  • [F1]The common stock was purchased pursuant to a Securities Purchase Agreement and were isused under the Issuer's 2021 Equity Incentive Plan on February 24, 2024.
  • [F2]These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on February 24, 2024. The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date.

Issuer

MAIA Biotechnology, Inc.

CIK 0001878313

Entity typeother

Related Parties

1
  • filerCIK 0001913253

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 4:11 PM ET
Size
6.9 KB